{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:10:48Z","timestamp":1790183448474,"version":"4.1.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007637","name":"Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["111554531651"],"award-info":[{"award-number":["111554531651"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2020.00220","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T06:55:13Z","timestamp":1595919313000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Decreased Deposition of Beta-Amyloid 1-38 and Increased Deposition of Beta-Amyloid 1-42 in Brain Tissue of Presenilin-1 E280A Familial Alzheimer\u2019s Disease Patients"],"prefix":"10.3389","volume":"12","author":[{"given":"Felix","family":"Dinkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Trujillo-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Villegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Streffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Mercken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Lopera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Glatzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Sepulveda-Falla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/s1474-4422(10)70323-9","article-title":"Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer\u2019s disease: a retrospective cohort study.","volume":"10","author":"Acosta-Baena","year":"2011","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-015-0159-5","article-title":"Diagnostic value of cerebrospinal fluid A\u03b2 ratios in preclinical Alzheimer\u2019s disease.","volume":"7","author":"Adamczuk","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jalz.2010.01.009","article-title":"Alzheimer\u2019s disease facts and figures.","volume":"6","year":"2010","journal-title":"Alzheimers Dement."},{"key":"B4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1523\/jneurosci.4067-07.2008","article-title":"Wild-type but not FAD mutant presenilin-1 prevents neuronal degeneration by promoting phosphatidylinositol 3-kinase neuroprotective signaling.","volume":"28","author":"Baki","year":"2008","journal-title":"J. Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/s1474-4422(11)70077-1","article-title":"Cerebral amyloid-\u03b2 PET with florbetaben (18F) in patients with Alzheimer\u2019s disease and healthy controls: a multicentre phase 2 diagnostic study.","volume":"10","author":"Barthel","year":"2011","journal-title":"Lancet Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.euroneuro.2005.04.003","article-title":"Prevalence of dementia in the elderly in Europe.","volume":"15","author":"Berr","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","article-title":"The genetics of Alzheimer disease: back to the future.","volume":"68","author":"Bertram","year":"2010","journal-title":"Neuron"},{"key":"B8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1474-4422(12)70259-4","article-title":"Genetic insights in Alzheimer\u2019s disease.","volume":"12","author":"Bettens","year":"2013","journal-title":"Lancet Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/bf00308809","article-title":"Neuropathological stageing of Alzheimer-related changes.","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"B10","first-page":"1","article-title":"Neuroanatomy and pathology of sporadic Alzheimer\u2019s disease.","volume":"215","author":"Braak","year":"2011","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00401-015-1419-y","article-title":"A\u03b243 is neurotoxic and primes aggregation of A\u03b240 in vivo.","volume":"130","author":"Burnouf","year":"2015","journal-title":"Acta Neuropathol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bbadis.2017.07.005","article-title":"A\u03b2 truncated species: implications for brain clearance mechanisms and amyloid plaque deposition.","volume":"1864","author":"Cabrera","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1038\/emboj.2012.79","article-title":"The mechanism of \u03b3-Secretase dysfunction in familial Alzheimer disease.","volume":"31","author":"Ch\u00e1vez-Guti\u00e9rrez","year":"2012","journal-title":"EMBO J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.1997.tb46140.x","article-title":"The beta-amyloid peptide, peptide self-assembly, and the emergence of biological activities. A new principle in peptide function and the induction of neuropathology.","volume":"814","author":"Cotman","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/humu.22117","article-title":"Locus-specific mutation databases for neurodegenerative brain diseases.","volume":"33","author":"Cruts","year":"2012","journal-title":"Hum. Mutat."},{"key":"B16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-cellbio-100109-104117","article-title":"Novel research horizons for presenilins and \u03b3-secretases in cell biology and disease.","volume":"26","author":"De Strooper","year":"2010","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006304","article-title":"Presenilins and \u03b3-secretase: structure, function, and role in Alzheimer Disease.","volume":"2","author":"De Strooper","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1159\/000121389","article-title":"Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease.","volume":"5","author":"Debatin","year":"2008","journal-title":"Neurodegener"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","article-title":"Classification and basic pathology of Alzheimer disease.","volume":"118","author":"Duyckaerts","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"31043","DOI":"10.1074\/jbc.m114.581165","article-title":"Alzheimer presenilin-1 mutations dramatically reduce trimming of long amyloid \u03b2-peptides (A\u03b2) by \u03b3-secretase to increase 42-to-40-residue A\u03b2.","volume":"289","author":"Fernandez","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ajpath.2013.05.005","article-title":"Pyroglutamate-3 amyloid-\u03b2 deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models.","volume":"183","author":"Frost","year":"2013","journal-title":"Am. J. Pathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1212\/wnl.45.3.461","article-title":"The consortium to establish a registry for Alzheimer\u2019s Disease (CERAD). Part X. neuropathology confirmation of the clinical diagnosis of Alzheimer\u2019s disease.","volume":"45","author":"Gearing","year":"1995","journal-title":"Neurology"},{"key":"B23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1474-4422(11)70055-2","article-title":"New lexicon and criteria for the diagnosis of Alzheimer\u2019s disease.","volume":"10","author":"Giaccone","year":"2011","journal-title":"Lancet Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neulet.2019.02.033","article-title":"A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer\u2019s disease.","volume":"701","author":"Gkanatsiou","year":"2019","journal-title":"Neurosci. Lett."},{"key":"B25","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.bbamem.2013.06.005","article-title":"\u03b3-Secretase inhibitors and modulators.","volume":"1828","author":"Golde","year":"2013","journal-title":"Biochim. Biophys. Acta."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1093\/brain\/122.9.1709","article-title":"The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer\u2019s disease brain: evidence for other phenotype-modifying factors.","volume":"122","author":"G\u00f3mez-Isla","year":"1999","journal-title":"Brain"},{"key":"B27","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/humu.20336","article-title":"Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40.","volume":"27","author":"Kumar-Singh","year":"2006","journal-title":"Hum. Mutat."},{"key":"B28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3233\/jad-130746","article-title":"Presenilin-1 mutations in Alzheimer\u2019s disease: an update on genotype-phenotype relationships.","volume":"37","author":"Larner","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/nm1096-1146","article-title":"The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology.","volume":"2","author":"Lemere","year":"1996","journal-title":"Nat. Med."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00051","article-title":"Effect of presenilin mutations on APP cleavage; insights into the pathogenesis of FAD.","volume":"8","author":"Li","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1007\/s00018-009-8435-9","article-title":"Presenilin-dependent regulated intramembrane proteolysis and gamma-secretase activity.","volume":"66","author":"McCarthy","year":"2009","journal-title":"Cell Mol. Life Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00401-012-1061-x","article-title":"APP mutations in the A\u03b2 coding region are associated with abundant cerebral deposition of A\u03b238.","volume":"124","author":"Moro","year":"2012","journal-title":"Acta Neuropathol."},{"key":"B33","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-017-0505-x","article-title":"Pyroglutamate and isoaspartate modified amyloid-beta in ageing and Alzheimer\u2019s disease.","volume":"6","author":"Moro","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1212\/wnl.46.3.673","article-title":"Apolipoprotein E epsilon4 association with dementia in a population-based study: the framingham study.","volume":"46","author":"Myers","year":"1996","journal-title":"Neurology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.1074\/jbc.m111.264473","article-title":"Structural basis for increased toxicity of pathological a\u03b242:a\u03b240 ratios in Alzheimer disease.","volume":"287","author":"Pauwels","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00401-012-1062-9","article-title":"Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease.","volume":"125","author":"Pera","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","article-title":"Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.","volume":"88","author":"Reitz","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/jnen\/nlv028","article-title":"Neuropathology of autosomal dominant Alzheimer Disease in the national Alzheimer coordinating center database.","volume":"75","author":"Ringman","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nn.2858","article-title":"Potent amyloidogenicity and pathogenicity of A\u03b243.","volume":"14","author":"Saito","year":"2011","journal-title":"Nat. Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev.ne.17.030194.002421","article-title":"Normal and abnormal biology of the beta-amyloid precursor protein.","volume":"17","author":"Selkoe","year":"1994","journal-title":"Annu. Rev. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1172\/jci66407","article-title":"Familial Alzheimer\u2019s disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis.","volume":"124","author":"Sepulveda-Falla","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/jad-2012-120907","article-title":"Phenotypic profile of early-onset familial Alzheimer\u2019s disease caused by presenilin-1 E280A mutation.","volume":"32","author":"Sepulveda-Falla","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1750-3639.2010.00469.x","article-title":"Deposition of hyperphosphorylated tau in cerebellum of PS1 E280A Alzheimer\u2019s disease.","volume":"21","author":"Sepulveda-Falla","year":"2011","journal-title":"Brain Pathol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/nen.0b013e31825e77de","article-title":"Stable size distribution of amyloid plaques over the course of Alzheimer disease.","volume":"71","author":"Serrano-Pozo","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-009-0521-4","article-title":"Variations in the neuropathology of familial Alzheimer\u2019s disease.","volume":"118","author":"Shepherd","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B46","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-016-0380-x","article-title":"pGluA\u03b2 increases accumulation of A\u03b2 in vivo and exacerbates its toxicity.","volume":"4","author":"Sofola-Adesakin","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-9-51","article-title":"Models of \u03b2-amyloid induced Tau-pathology: the long and \u201cfolded\u201d road to understand the mechanism.","volume":"9","author":"Stancu","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"B48","doi-asserted-by":"crossref","first-page":"443.e14","DOI":"10.1016\/j.cell.2017.07.004","article-title":"Alzheimer\u2019s-causing mutations shift A\u03b2 length by destabilizing \u03b3-Secretase-A\u03b2n Interactions.","volume":"170","author":"Szaruga","year":"2017","journal-title":"Cell"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1084\/jem.20150892","article-title":"Qualitative changes in human \u03b3-secretase underlie familial Alzheimer\u2019s disease.","volume":"212","author":"Szaruga","year":"2015","journal-title":"J. Exp. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-014-1375-y","article-title":"Neuropathology and biochemistry of A\u03b2 and its aggregates in Alzheimer\u2019s disease.","volume":"129","author":"Thal","year":"2015","journal-title":"Acta Neuropathol."},{"key":"B51","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201947996","article-title":"A\u03b243-producing PS1 FAD mutants cause altered substrate interactions and respond to \u03b3-secretase modulation.","volume":"21","author":"Trambauer","year":"2020","journal-title":"EMBO Rep."},{"key":"B52","article-title":"Neuropathological, neuropsychological, and imagenological comparison between sporadic Alzheimer\u2019s disease and ps1-e280a.","volume":"10","author":"Trujillo-Rodr\u00edguez","year":"2014","journal-title":"Alzheimer\u2019s Dementia J. Alzheimer\u2019s Assoc."},{"key":"B53","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2119\/2007-00094.vanvickle","article-title":"Presenilin-1 280Glu\u2013>Ala mutation alters C-terminal APP processing yielding longer abeta peptides: implications for Alzheimer\u2019s disease.","volume":"14","author":"Van Vickle","year":"2008","journal-title":"Mol. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/ana.410300503","article-title":"Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study.","volume":"30","author":"Vonsattel","year":"1991","journal-title":"Ann. Neurol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1152\/physiol.00009.2008","article-title":"Presenilins: members of the gamma-secretase quartets, but part-time soloists too.","volume":"23","author":"Wakabayashi","year":"2008","journal-title":"Physiology"},{"key":"B56","article-title":"Plasma pyroglutamate-modified amyloid beta differentiates amyloid pathology.","volume":"12","author":"Wang","year":"2020","journal-title":"Alzheimers Dement"},{"key":"B57","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1471-4159.2009.06170.x","article-title":"Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains.","volume":"110","author":"Welander","year":"2009","journal-title":"J. Neurochem."},{"key":"B58","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/sj.embor.7400896","article-title":"When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42\/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease.","volume":"8","author":"Wolfe","year":"2007","journal-title":"EMBO Rep."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2020.00220\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T06:55:25Z","timestamp":1595919325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2020.00220\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":58,"alternative-id":["10.3389\/fnagi.2020.00220"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2020.00220","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]},"article-number":"220"}}